As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Redefining Data Centers: Innovation, Sustainability, and the Future of Construction | Lincoln Wood, Edged
Built Environment Matters
37 minutes
1 year ago
Redefining Data Centers: Innovation, Sustainability, and the Future of Construction | Lincoln Wood, Edged
Welcome to another episode of Built Environment Matters! This month, Jaimie Johnston MBE, Head of Global Systems at Bryden Wood, is joined by Lincoln Wood, Director of Design at Edged, to discuss the transformative power of data centers in the digital age. With his extensive background in complex projects, Lincoln brings a wealth of knowledge on how Edged is approaching data center design with an engineering-first mindset. In this conversation, they delve into the rise of AI, the increasing e...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
